CG Oncology, Inc. (CGON) insider trading.
In Q3 2026, insiders at CG Oncology, Inc. reported 8 non-derivative transactions on 4 Forms 3, 4 and 5: 0 open-market purchases and 4 sales worth $2.0M.
- Transactions
- 8
- Purchases (P)
- 0
- Sales (S)
- 4
- Net shares, P minus S
- -27,165
- Insiders
- 2
- Last filed
- 2026-09-17
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Post Leonard E | Director | 6 | 0 | 3 |
| Mulay James | Director | 2 | 0 | 1 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-15 | Post Leonard E | M (A) | 1,000 | $0.6 | 1,000 | Form 4 |
| 2026-09-15 | Post Leonard E | S (D) | 1,000 | $72.98 | 0 | Form 4 |
| 2026-08-14 | Post Leonard E | S (D) | 1,000 | $74.54 | 0 | Form 4 |
| 2026-08-14 | Post Leonard E | M (A) | 1,000 | $0.6 | 1,000 | Form 4 |
| 2026-07-15 | Post Leonard E | S (D) | 1,000 | $71.17 | 0 | Form 4 |
| 2026-07-15 | Post Leonard E | M (A) | 1,000 | $0.6 | 1,000 | Form 4 |
| 2026-07-10 | Mulay James | M (A) | 24,165 | $26.63 | 24,165 | Form 4 |
| 2026-07-10 | Mulay James | S (D) | 24,165 | $75.16 | 0 | Form 4 |
Transaction codes in this quarter
Get CGON insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1991792&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · CGON company page · CG Oncology, Inc. on SEC.gov
Questions
Are insiders buying or selling CG Oncology, Inc. (CGON)?
In Q3 2026, insiders at CG Oncology, Inc. reported 8 non-derivative transactions on 4 Forms 3, 4 and 5: 0 open-market purchases and 4 sales worth $2.0M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these CG Oncology, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/cgon.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.